Clinical Trial Update: A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy [Phase 3]

View source ↗

Summary

Clinical trial update notes a Phase 3 study evaluating the long-term safety and tolerability of brivaracetam in children with Childhood absence epilepsy or Juve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Absence Epilepsy
• Juvenile Absence Epilepsy

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Childhood Absence Epilepsy, Juvenile Absence Epilepsy | Phase 3 | Status: RECRUITING